Switzerland· 65205006
Moventig 25 mg, Filmtabletten
A naloxegol product containing naloxegolum, registered in Switzerland by Cederberg GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Naloxegol is registered in 15 of 19 countries.
Countries holding a registration under ATC A06AH03 (naloxegol), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Naloxegol · ATC A06AH03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of naloxegol costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $3.62 in Italy to $5.84 in Spain — a ×1.6 gap.
- Switzerland: $5.75 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Naloxegol · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- ES Spain$5.84
- CH Switzerland$5.75
- FR France$3.80
- IT Italy$3.62
The record
At a glance
Swissmedic (Switzerland)- Active substance
- naloxegolum
- Manufacturer
- Cederberg GmbH
- Country
- Switzerland (CH)
- ATC code
- A06AH03
- ATC class
- Naloxegol
- Defined daily dose
- 25 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768065205006130 StkCHF 99.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
204 interactions on record for naloxegol.
Graded by severity as the source publishes them — 66 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naloxegol · interactions on record
204 records
- 66 severe
- 57 moderate
- 81 minor
Most severe, free to view
- AprepitantA04AD12severe
- DanazolG03XA01severe
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naloxegol in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainMOVENTIG 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGrünenthal Gmbh
- FranceMOVENTIG 25 mg, comprimé pelliculéGRUNENTHAL
- IcelandMoventigGrünenthal GmbH*
- NetherlandsMoventig 25 mg filmomhulde tablettenGrunenthal GmbH
- NorwayMoventigGrünenthal GmbH
- PolandMoventigGruenenthal GmbH
- SwedenMoventig 25 mg Filmdragerad tablettGrünenthal GmbH
- United KingdomMoventig 12.5mg tabletsGrunenthal Ltd
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Moventig
- Iceland · Moventig
- Liechtenstein · Moventig
- Norway · Moventig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc8e75ff-e1aa-4549-961a-4cbfcf243270 GET /v1/drugs/dc8e75ff-e1aa-4549-961a-4cbfcf243270?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "naloxegolum 25 mg",
"valid_from": "2021-01-01",
"limitations": "[{\"description\":\"Bei erwachsenen Patienten, die seit mehr als 4 Wochen wegen chronischer nicht-tumorassoziierter Schmerzen mit Opioiden behandelt werden und trotz mindestens 4-wöchiger Zusatztherapie mit Laxantien verschiedener Klassen eine therapierefraktäre opioid-induzierte Obstipation aufweisen, d.h. weniger als 3 Defäkationen/Woche und mindestens 1 Zusatzsymptom bei der Defäkation (starkes Pressen und/oder klumpiger oder harter Stuhl, und/oder Gefühl der unvollständigen Entleerung und/oder Gefühl des Verschlusses).<br>\\nBei Nichtansprechen auf MOVENTIG innerhalb von 4 Wochen (Erhöhung der Stuhlfrequenz um mindestens 1/Woche und Abnahme von mindestens einem der Zusatzsymptome) muss das Präparat abgesetzt werden.<br>\\nDie Therapie mit MOVENTIG > 52 Wochen bedarf einer Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.\\n\\n\\n\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2016-01-01\"}]",
"galenic_form": "Filmtabl 25 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2016-01-01",
"self_retention_pct": 10
}See everything about naloxegol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.